174 related articles for article (PubMed ID: 31858365)
1. Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency.
Abolhassani H; El-Sherbiny YM; Arumugakani G; Carter C; Richards S; Lawless D; Wood P; Buckland M; Heydarzadeh M; Aghamohammadi A; Hambleton S; Hammarström L; Burns SO; Doffinger R; Savic S
J Clin Immunol; 2020 Feb; 40(2):277-288. PubMed ID: 31858365
[TBL] [Abstract][Full Text] [Related]
2. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
3. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.
Zheng J; Chan PL; Liu Y; Qin G; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
PLoS One; 2013; 8(12):e82203. PubMed ID: 24312642
[TBL] [Abstract][Full Text] [Related]
4. Impaired selective cytokine production by CD4(+) T cells in Common Variable Immunodeficiency associated with the absence of memory B cells.
Berrón-Ruiz L; López-Herrera G; Vargas-Hernández A; Santos-Argumedo L; López-Macías C; Isibasi A; Segura-Méndez NH; Bonifaz L
Clin Immunol; 2016 May; 166-167():19-26. PubMed ID: 27057998
[TBL] [Abstract][Full Text] [Related]
5. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
6. Astute Clinician Report: A Novel 10 bp Frameshift Deletion in Exon 2 of ICOS Causes a Combined Immunodeficiency Associated with an Enteritis and Hepatitis.
Robertson N; Engelhardt KR; Morgan NV; Barge D; Cant AJ; Hughes SM; Abinun M; Xu Y; Koref MS; Arkwright PD; Hambleton S
J Clin Immunol; 2015 Oct; 35(7):598-603. PubMed ID: 26399252
[TBL] [Abstract][Full Text] [Related]
7. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
[TBL] [Abstract][Full Text] [Related]
8. T helper 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of inducible T-cell costimulator.
Jiao Q; Qian Q; Liu C; Luo Y; Fang F; Wang M; Ji J; Qian H; Zhang X; Maurer M
Br J Dermatol; 2020 Mar; 182(3):648-657. PubMed ID: 31090221
[TBL] [Abstract][Full Text] [Related]
9. A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation.
Clemente N; Boggio E; Gigliotti CL; Orilieri E; Cappellano G; Toth E; Valletti PA; Santoro C; Quinti I; Pignata C; Notarangelo LD; Dianzani C; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
Genes Immun; 2015 Mar; 16(2):151-61. PubMed ID: 25569260
[TBL] [Abstract][Full Text] [Related]
10. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
[TBL] [Abstract][Full Text] [Related]
11. [High expression of ICOS on CD4
Chen X; Wang F; Cong X; Shen Q; Chen L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1102-1108. PubMed ID: 33325362
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID.
Liu A; Liu Q; Leng S; Zhang X; Feng Q; Peng J; Feng G
Clin Exp Immunol; 2023 Mar; 211(1):68-77. PubMed ID: 36571238
[TBL] [Abstract][Full Text] [Related]
13. Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications.
Abyazi ML; Bell KA; Gyimesi G; Baker TS; Byun M; Ko HM; Cunningham-Rundles C; Feng F; Maglione PJ
J Allergy Clin Immunol; 2022 Jan; 149(1):315-326.e9. PubMed ID: 34146579
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production.
Liu Z; Liu S; Zhang Y; Zeng W; Wang S; Ji P; Pan M; Zhu C; Wang Y
Cell Immunol; 2021 Oct; 368():104420. PubMed ID: 34418679
[TBL] [Abstract][Full Text] [Related]
15. CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function.
Goenka R; Xu Z; Samayoa J; Banach D; Beam C; Bose S; Dooner G; Forsyth CM; Lu X; Medina L; Sadhukhan R; Sielaff B; Sousa S; Tao Q; Touw D; Wu F; Kingsbury GA; Akamatsu Y
J Immunol; 2021 Mar; 206(5):1102-1113. PubMed ID: 33495237
[TBL] [Abstract][Full Text] [Related]
16. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
[TBL] [Abstract][Full Text] [Related]
17. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
Front Immunol; 2021; 12():786680. PubMed ID: 34925367
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation.
Wiley RE; Goncharova S; Shea T; Johnson JR; Coyle AJ; Jordana M
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):722-30. PubMed ID: 12760969
[TBL] [Abstract][Full Text] [Related]
19. Repressor of GATA-3 can negatively regulate the expression of T cell cytokines through modulation on inducible costimulator.
Zang YS; Fang Z; Liu YA; Li B; Xiu QY
Chin Med J (Engl); 2012 Jun; 125(12):2188-94. PubMed ID: 22884151
[TBL] [Abstract][Full Text] [Related]
20. ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells.
Wassink L; Vieira PL; Smits HH; Kingsbury GA; Coyle AJ; Kapsenberg ML; Wierenga EA
J Immunol; 2004 Aug; 173(3):1779-86. PubMed ID: 15265908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
